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INTRODUCTION
Poisonings among young people are an 
important but potentially avoidable cause of 
morbidity and mortality.1,2 They are one of the 
leading causes of death at this age, including 
some unintentional, but primarily self-harm 
events.3,4 In the UK, self-harm affects up 
to 1 in 7 young people5–7 with poisonings 
accounting for 77–91% of all medically-
attended self-harm episodes.8–10 Young 
people who have self-poisoned are 10–32 
times more likely to complete suicide over 
the next 10 years than those who have not.11 
As outlined in the national Suicide Prevention 
Strategy, primary care has a key role to play 
in managing those at risk of self-harm.12 
Up-to-date information on the substances 
involved in poisonings among young people 
is needed to guide prescribing decisions 
as well as the advice offered to individuals 
at risk and their families. However, at a 
population level in the UK, these data are 
lacking.
Young people represent a distinct 
population in terms of risk of self-harm 
and clinician prescribing practices. Most 
UK data describing poisoning substances 
among young people have been based 
on attendances at specific hospitals or 
emergency departments (EDs) with limited 
generalisability,8,9,13 have combined data on 
young people and adults,14–16 or are now out 
of date.17 International data are now largely 
out of date;18–23 however, two US studies 
have described poisoning substances in 
young people presenting to services up to 
2013,24,25 one of which solely examined opiate 
poisonings.25 
This study aimed to estimate population 
level medically-attended poisoning incidence 
among 10–24-year-olds in England between 
1998 and 2014 according to poisoning 
substance by sex, age, deprivation level, and 
changes over time.
METHOD
Study population
This study utilised routinely collected 
General Practice data from the Clinical 
Practice Research Datalink (CPRD). In the 
UK, 98% of the population is registered with 
a GP,26 and primary care records include 
information on all healthcare attendances. 
CPRD includes anonymised medical records 
from, at the point of data extraction, 674 UK 
general practices, 395 of which had health 
records linked to Hospital Episode Statistics 
(HES) data (recording hospital admissions in 
England), and Office for National Statistics 
(ONS) mortality data. Using these three 
linked data sources improves poisoning 
ascertainment compared to CPRD or HES 
data alone.27,28 The study population was 
an open cohort of young people registered 
with a HES–ONS linked CPRD practice and 
aged 10–24 years between 1 April 1998 
and 31 March 2014. This cohort has been 
described in detail elsewhere.29
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Outcome events
The study outcome was a poisoning event 
occurring within the study period and 
recorded within any one of the three linked 
data sources. Repeat poisoning events 
within the same individual were included. 
Time dependent algorithms that have been 
previously developed27 excluded duplicate 
codes recording the same poisoning events 
(Figure 1). For ONS mortality data, only 
primary cause of death codes were included.
Poisonings, and their intent, were identified 
using a combination of International 
Classification of Diseases (ICD)-10 codes 
(T36–65, X40–49, X60–69, Y10–19, and Y90–91) 
in HES/ONS data and Read Codes in CPRD 
data. Poisoning substances were categorised 
using ICD-10 categories T35–65, excluding 
venomous animal and food poisonings 
(T61, T63, and T64). The comprehensive 
poisoning code list used has been described 
elsewhere.29 All substances recorded 
for a poisoning event have been included. 
Therefore, one poisoning event may have had 
more than one contributing substance.
Statistical analysis
The number and percentage of poisoning 
events involving specific substances was 
identified. Incidence rates (IR) per 100 000 
person-years (PY) and 95% confidence 
intervals (95% CI) were calculated by 
sex, age, socioeconomic deprivation, 
geographical area, and calendar year for 
the five most common substances, as well 
unspecified substance poisonings and total 
poisonings. For clinical relevance, poisonings 
involving non-steroidal anti-inflammatory 
drugs (NSAIDs) (T39.3) and aspirin (T39.0) 
were combined for calculating incidence 
rates, as were all antidepressants (T43.0–
T43.2). Age and year were included as time-
varying covariates by Lexis expansion. Time 
period was analysed in single years in the 
univariate analysis and 4-year bands in the 
multivariate analysis. Socioeconomic status 
was assessed using quintiles of the Index of 
Multiple Deprivation 2010 (IMD) for England. 
This was provided by CPRD, at a lower 
super output area level (approximately 650 
households), based on the postcode of the 
individual’s GP practice.
Adjusted incidence rate ratios (aIRR) 
were calculated for the five most common 
substances, total poisonings (regardless of 
whether an exact substance was recorded 
for the poisoning or not) and unspecified 
substance poisonings using negative 
binomial regression, and adjusted for each 
of the covariates outlined above. Potential 
interactions were assessed including sex 
and age,9 time and sex,9 time and age,20 time 
and socioeconomic deprivation, with P<0.01 
taken as significant. Where significant 
interactions were found, stratified incidence 
rates are presented. Data were analysed 
using Stata/SE (version 13). 
RESULTS
The cohort contained 1 736 527 young people 
contributing 7 209 529 person-years of 
follow-up: 52% were female (Table 1). In total, 
40 333 poisoning events were recorded from 
31 509 young people. Of those, 23 326 (57.8%) 
had poisoning substance(s) recorded. One-
third (31.8%) had more than one poisoning 
How this fits in
Poisonings are by far the most common 
form of medically-attended self-harm 
among young people and are often 
avoidable, but up-to-date information on 
the substances young people are being 
poisoned by is lacking. This study shows 
the most common substances involved 
in poisonings among 10–24-year-olds in 
England are paracetamol, alcohol, NSAIDs, 
antidepressants, and opioids. Between 1998 
and 2014 there was a fivefold increase in 
opioid poisonings among 10–24-year-olds, 
as well as a three- to fourfold increase in 
antidepressant poisonings. Poisonings show 
a close relationship with deprivation, with the 
incidence of poisoning from all substances 
rising with increasing socioeconomic 
deprivation.
1 736 527 cohort members
1 705 018 individuals with no poisoning 
event
31 509 individuals with 
107 986 poisoning codes
54 996 codes duplicating recording of 
the same poisoning events with no 
additional substance detail
52 990 codes recording
40 333 poisoning events 
among 31 509 individuals
17 007 events with specific 
substance not specified or 
unknown
15 906 events with one 
specific poisoning 
substance recorded
7420 events with more 
than one specific poisoning 
substance recorded
Figure 1. Number of poisoning codes and 
events.
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substance recorded (Figure 1). Two-thirds 
(66.5%) of all poisonings were recorded as 
intentional, 7.5% unintentional, and 26.0% of 
undetermined or unspecified intent.
Most common substances
Paracetamol was the most commonly 
involved substance (39.8%, Table 2). The other 
most common substances were ethanol 
(drinking alcohol) (32.7%), NSAIDs (11.6%), 
other/unspecified antidepressants (includes 
selective serotonin reuptake inhibitors 
[SSRIs] and serotonin and norepinephrine 
reuptake inhibitors [SNRIs]) (10.2%), other 
opioids (includes codeine, tramadol, and 
morphine) (7.6%), benzodiazepines (4.6%), 
aspirin (4.6%), psychostimulants (includes 
amphetamines, methylphenidate, and 
ecstasy) (4.2%), other antiepileptic/sedative 
hypnotic drugs (includes Z-drugs, such as 
zopiclone) (3.2%), and tricyclic/tetracyclic 
antidepressants (2.7%). 
Age and sex variations
Poisoning incidence according to age varied 
between males and females (Figure 2) 
(P<0.001 for each substance). The peak 
poisoning incidence in females was in the 
16–18-year age group for all substances 
other than antidepressants (for example, 
aIRR 2.55, 95% CI = 2.12 to 3.07 for 
16–18-year-olds compared to 10–15-year-
olds for opioid poisonings, Table 3). The peak 
poisoning incidence in males was in the 
oldest age group for all substances (for 
example, aIRR 8.68, 95% CI = 6.68 to 11.28 for 
19–24-year-olds compared to 10–15-year-
olds for aspirin/NSAID poisonings).
Changes over time
Poisonings increased more over time among 
females than males for each of the five 
most common substances (Figure 2). For 
paracetamol, aspirin/NSAID, opioid, and 
antidepressant poisonings this was most 
marked among 16–18-year-old females 
(for example, paracetamol poisonings, 
IR 171.6 per 100 000 person-years (PY), 
95% CI = 123.8 to 237.9 in 1998–1999 to 
501.3 per 100 000 PY, 95% CI = 439.1 to 571.6 
in 2013–2014). There was a sharp rise in 
paracetamol poisonings among 10–15-year-
old females in the most recent 2 years 
(IR 142.3 per 100 000 PY, 95% CI = 120.4 to 
168.3 in 2011–2012 to 290.0, 95% CI = 255.6 to 
329.1 in 2013–2014). For poisonings involving 
alcohol, the biggest increase was among 
19–24-year-old females (IR 85.4 per 100 000 
PY, 95% CI = 62.1 to 117.4 in 1998–1999 to 
185.2, 95% CI = 159.2 to 215.4 in 2013–2014).
Though smaller than among females, 
the increases seen over time among males 
were largest in the 19–24-year age group for 
each of the five most common substances. 
The biggest of these increases was for 
opioid poisonings (IR 6.6 per 100 000 PY, 
95% CI = 2.1 to 20.3 in 1998–1999 to 47.6, 
95% CI = 35.3 to 64.2 in 2013–2014). 
Poisoning events involving alcohol among 
10–14-year-old males decreased over time 
(IR 94.4 per 100 000 PY, 95% CI = 71.4 to 124.9 
in 1998–1999 to 31.2, 95% CI = 21.4 to 45.5 
in 2013–2014). There was also a reduction 
in unspecified substance poisonings among 
16–18-year-old females from their peak 
in 2001–2002 (IR 601.8 per 100 000 PY, 
95% CI = 525.5 to 689.2) to 2013–2014 (437.6 
per 100 000 PY, 95% CI = 380.0 to 503.9) 
After adjusting for available confounders, 
poisonings involving the five most common 
substances all increased steadily between 
1998 and 2014 in both sexes. The largest 
Table 1. Characteristics of the cohort
 Participants, n (%), N = 1 736 527
 No poisoning events, At least one poisoning event, 
Characteristics N = 1 705 018 N = 31 509 
Sex 
 Male 812 770 (48) 12 345 (39) 
 Female 892 248 (52) 19 164 (61)
Median age, years, (IQR) entering cohort  16.3 (10.0–21.5) 13.9 (10.0–18.5)
Median person-years (IQR) contributed  2.8 (1.1–6.3) 6.7 (3.2–10.2)
Index of Multiple Deprivation quintile 
 1 (least deprived) 231 391 (14) 3021 (10) 
 2 362 948 (21) 5834 (18) 
 3 340 261 (20) 6867 (22) 
 4 392 703 (23) 7826 (25) 
 5 (most deprived) 377 715 (22) 7961 (25)
IQR = interquartile range.
Table 2. Ten most common poisoning substances by five character 
ICD-10 code
 Poisoning events including  Events involving 
Substance (by 5 character ICD-10 code) named substance, n substance, % (N = 23 326)
T39.1  4-Aminophenol derivatives (paracetamol) 9289 39.8
T51.0  Ethanol (drinking alcohol) 7635 32.7
T39.3  Other non-steroidal anti-inflammatory drugs [NSAIDs] 2696 11.6
T43.2  Other and unspecified antidepressants (includes SSRIs) 2373 10.2
T40.2  Other opioids 1766 7.6
T42.4  Benzodiazepines 1075 4.6
T39.0  Salicylates (aspirin) 1072 4.6
T43.6  Psychostimulants with abuse potential 976 4.2
T42.6  Other antiepileptic and sedative hypnotic drugs 736 3.2
T43.0  Tricyclic and tetracyclic antidepressants 624 2.7 
Italics not included in ICD-10 description but added by the authors for explanation. ICD = International Classification 
of Diseases. SSRIs = selective serotonin reuptake inhibitors. 
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increases saw opioid poisonings increase 
fivefold from 1998–2014 (females: aIRR 5.30, 
95% CI = 4.08 to 6.89, males: aIRR 5.11, 
95% CI = 3.37 to 7.76), antidepressant 
poisonings three- to fourfold (females: 
aIRR 3.91, 95% CI = 3.18 to 4.80, males: 
aIRR 2.70, 95% CI = 2.04 to 3.58), aspirin/
NSAID poisonings threefold (females: 
aIRR 2.84, 95% CI = 2.40 to 3.36, males: 
2.76, 95% CI = 2.05 to 3.72), and paracetamol 
poisonings threefold in females (aIRR 2.87, 
95% CI = 2.58 to 3.20). Unspecified 
substance poisonings decreased over time 
in both sexes, by 12% in females (aIRR 0.88, 
95% CI = 0.81 to 0.95) and 21% in males 
(aIRR 0.79, 95% CI = 0.72 to 0.86) (Table 3).
Socioeconomic variations
A social gradient in poisonings was 
demonstrated for each substance with a 
roughly twofold increase in poisoning 
incidence for the most compared to least 
deprived groups. Excluding unspecified 
poisonings, the steepest gradient was for 
opioid poisonings in males with a 3.5 fold 
increase in poisoning incidence in the most 
compared to least deprived group (aIRR 3.46, 
95% CI = 2.24 to 5.36) (Table 3).
DISCUSSION
Summary
The most common substances involved 
in poisonings among 10–24-year-olds 
were paracetamol, alcohol, NSAIDs, 
antidepressants, and opioids. There were 
increases in poisoning incidence rates of 
between three- and fivefold for opioids, 
antidepressants, aspirin/NSAIDs and 
paracetamol over the study period. Sex and 
age variation was shown with the largest rises 
over time being in 16–18-year-olds among 
females and 19–24-year-olds among males. 
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(b) Paracetamol in females
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(c) Aspirin/NSAIDs in males
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(d) Aspirin/NSAIDs in females
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(e) Opioids in males
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(f) Opioids in females
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(a) Paracetamol in males
Age 10–15 years
Age 16–18 years
Age 19–24 years
Figure 2. Incidence rates by age over time 
for a) poisonings involving paracetamol in 
males, b) poisonings involving paracetamol 
in females, c) poisonings involving aspirin/
NSAIDs in males, d) poisonings involving 
aspirin/NSAIDs in females, e) poisonings 
involving opioids in males, f) poisonings 
involving opioids in females.
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There was a social gradient in poisonings for 
each of the five most common substances, 
with higher poisoning incidence in the most 
deprived groups. 
Strengths and limitations
This is the first study to use population 
level combined English healthcare data 
sources to examine the substances involved 
in poisoning episodes among young people. 
As CPRD has been shown to be broadly 
representative of the UK population,30 these 
results should be generalisable to the wider 
UK and other similar countries. This study 
is among the largest to examine poisoning 
substances in young people worldwide. 
The use of three linked databases should 
have resulted in greater ascertainment 
of poisoning incidence than studies using 
single data sources from localised areas or 
using CPRD or HES data alone.27,28
Limitations of this study include 
underestimation of poisoning incidence 
for specific substances as only 57.8% of 
the poisonings had substances involved 
recorded. These results showed a reduction 
in unspecified or unknown substance 
poisonings over time, but as the absolute 
rate reductions among unspecified or 
unknown poisonings were much smaller 
than the absolute rate increases seen for 
the five most common substances, improved 
recording over time cannot fully explain the 
incidence rate increases found for these 
substances. It was only possible to obtain 
deprivation data based on the IMD score of an 
individual’s GP practice address, which may 
not always accurately represent an individual 
household’s deprivation level. Finally, 
because of the large sample size some 
statistically significant results that are not 
clinically important may have been detected.
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(g) Antidepressants in males
19
98
–9
9
19
99
–0
0
20
00
–0
1
20
01
–0
2
20
02
–0
3
20
03
–0
4
20
04
–0
5
20
05
–0
6
20
06
–0
7
20
08
–0
9
20
07
–0
8
20
09
–1
0
20
10
–1
1
20
11
–1
2
20
12
–1
3
20
13
–1
4
0
50
100
150
200
250
P
oi
so
ni
ng
 r
at
e 
(p
er
 1
00
 0
00
 P
Y)
(h) Antidepressants in females
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(i) Alcohol in males
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(j) Alcohol in females
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(k) Unspecified substances in males
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(l) Unspecified substances in females
Age 10–15 years
Age 16–18 years
Age 19–24 years
Figure 2 continued. g) poisonings involving 
antidepressants in males, h) poisonings involving 
antidepressants in females, i) poisonings 
involving alcohol in males, j) poisonings involving 
alcohol in females, k) unspecified substance 
poisonings in males, l) unspecified substance 
poisonings in females.
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Comparison with existing literature
The finding that the most common 
substances involved in poisoning were 
over-the-counter (OTC) analgesics is 
consistent with previous studies from the 
UK,8,9,13,31 US,18,24 and Australia.32 In the 
current findings, alcohol was the second 
most common substance involved, similar 
to findings among comparable age groups in 
Finland,20 Norway,22 the US,18 and emergency 
department (ED) attendances for any form of 
self-harm among 12–25-year-olds in Leeds, 
England.8
The most up-to-date UK poisoning 
substance data comes from the Multicentre 
Study of Self-harm, reporting ED data from 
five hospitals across three English cities 
from 2003–2012 in people aged >15 years. 
This showed 46% of poisonings involved 
paracetamol or salicylates, 25% 
antidepressants, 14% benzodiazepines, 
and 7% major tranquilisers and/or 
antipsychotics.16 Though there are similarities 
with the most common substances 
demonstrated in the current study, the most 
notable difference is the presence of opioids 
among the most common substances 
reported here, suggesting they may be a 
more common poisoning substance among 
young people than other adults. 
Though the authors are not aware of 
recent data on temporal trends in opioid 
poisonings in the UK, data from US national 
hospital discharges show almost doubling of 
opioid poisonings among 15–19-year-olds 
between 1997 and 2012.25 The current results 
suggest this increase may be larger among 
10–24-year-olds in the UK, with a fivefold 
Table 3. Adjusted poisoning incidence rate ratios for five most common substances, total poisonings and 
unspecified/unknown substance poisonings 
 Adjusted poisoning incidence rate ratios (95% CIs)
 All poisonings Paracetamol Aspirin/NSAIDs  Antidepressants  Unspecified/ 
 combined (T39.1) (T39.0 & T39.3) Opioids (T40.2) (T43.0, T43.1, T43.2) Alcohol (T51.0) unknown substance 
 (n = 40 333) (n = 9 289) (n = 3 618) (n = 1 766)  (n = 2 945) (n = 7 635) (n = 17 007)
Females
Age group, years 
 10–15 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 16–18 2.60 (2.49 to 2.72) 2.40 (2.20 to 2.61) 2.13 (1.87 to 2.43) 2.55 (2.12 to 3.07) 4.73 (3.93 to 5.69) 2.19 (1.98 to 2.44) 3.39 (3.16 to 3.63) 
 19–24 1.83 (1.76 to 1.91) 1.33 (1.23 to 1.43) 1.42 (1.26 to 1.78) 2.11 (1.78 to 2.49) 6.17 (5.23 to 7.28) 1.73 (1.58 to 1.90) 2.62 (2.46 to 2.80)
Calendar period 
 1998/99–2001/02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 2002/03–2005/06 1.20 (1.14 to 1.27) 1.52 (1.36 to 1.70) 1.49 (1.25 to 1.78) 1.56 (1.19 to 2.04) 1.46 (1.18 to 1.82) 1.43 (1.26 to 1.64) 1.12 (1.03 to 1.21) 
 2006/07–2009/10 1.25 (1.19 to 1.32) 2.16 (1.94 to 2.41) 2.51 (2.13 to 2.97) 3.77 (2.90 to 4.90) 1.79 (1.45 to 2.21) 1.88 (1.65 to 2.13) 0.89 (0.82 to 0.96) 
 2010/11–2013/14 1.48 (1.40 to 1.56) 2.87 (2.58 to 3.20) 2.84 (2.40 to 3.36) 5.30 (4.08 to 6.89) 3.91 (3.18 to 4.80) 2.24 (1.97 to 2.55) 0.88 (0.81 to 0.95)
IMD quintile 
 1 (least deprived) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 2 1.50 (1.41 to 1.60) 1.33 (1.18 to 1.50) 1.30 (1.08 to 1.56) 1.56 (1.19 to 2.04) 2.00 (1.57 to 2.54) 1.55 (1.34 to 1.80) 1.51 (1.37 to 1.66) 
 3 1.76 (1.65 to 1.88) 1.40 (1.24 to 1.59) 1.20 (1.00 to 1.45) 1.58 (1.20 to 2.09) 1.63 (1.27 to 2.08) 1.65 (1.42 to 1.92) 2.21 (2.00 to 2.43) 
 4 2.02 (1.90 to 2.15) 1.60 (1.42 to 1.81) 1.47 (1.22 to 1.76) 1.70 (1.31 to 2.22) 2.49 (1.96 to 3.17) 1.98 (1.71 to 2.29) 2.37 (2.15 to 2.61) 
 5 (most deprived) 2.02 (1.90 to 2.16) 1.66 (1.47 to 1.88) 1.52 (1.26 to 1.76) 2.12 (1.63 to 2.76) 2.29 (1.80 to 2.92) 1.82 (1.57 to 2.11) 2.23 (2.02 to 2.46)
Males
Age group, years 
 10–15 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 16–18 2.48 (2.34 to 2.62) 4.59 (3.86 to 5.31) 6.52 (4.92 to 8.63) 7.19 (4.83 to 10.71) 7.26 (5.23 to 10.08) 2.36 (2.12 to 2.62) 2.02 (1.87 to 2.19) 
 19–24 3.17 (3.01 to 3.34) 7.12 (6.15 to 8.24) 8.68 (6.68 to 11.28) 13.02 (8.94 to 18.96) 18.56 (13.67 to 25.21) 2.37 (2.15 to 2.61) 2.48 (2.30 to 2.67)
Calendar period 
 1998/99–2001/02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 2002/03–2005/06 1.03 (0.96 to 1.09) 1.16 (0.98 to 1.37) 1.62 (1.19 to 2.20) 1.87 (1.20 to 2.93) 1.05 (0.78 to 1.43) 0.97 (0.86 to 1.10) 1.02 (0.94 to 1.11) 
 2006/07–2009/10 1.06 (1.00 to 1.12) 1.81 (1.55 to 2.12) 2.85 (2.13 to 3.82) 4.17 (2.75 to 6.32) 1.51 (1.13 to 2.01) 1.15 (1.02 to 1.29) 0.93 (0.86 to 1.01) 
 2010/11–2013/14 1.01 (0.95 to 1.07) 1.79 (1.53 to 2.10) 2.76 (2.05 to 3.72) 5.11 (3.37 to 7.76) 2.70 (2.04 to 3.58) 1.24 (1.10 to 1.39) 0.79 (0.72 to 0.86)
IMD quintile 
 1 (least deprived) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 2 1.62 (1.50 to 1.75) 1.49 (1.22 to 1.81) 1.80 (1.30 to 2.49) 1.86 (1.18 to 2.94) 1.89 (1.32 to 2.72) 1.34 (1.16 to 1.55) 1.86 (1.65 to 2.10) 
 3 2.51 (2.32 to 2.72) 1.35 (1.10 to 1.65) 1.47 (1.05 to 2.07) 1.72 (1.07 to 2.74) 1.98 (1.37 to 2.86) 1.61 (1.39 to 1.87) 4.30 (3.83 to 4.82) 
 4 2.66 (2.46 to 2.88) 1.63 (1.34 to 1.97) 1.73 (1.24 to 2.41) 2.22 (1.41 to 3.48) 2.24 (1.57 to 3.21) 1.68 (1.45 to 1.94) 4.63 (4.13 to 5.20) 
 5 (most deprived) 2.62 (2.42 to 2.83) 2.16 (1.79 to 2.62) 1.94 (1.40 to 2.70) 3.46 (2.24 to 5.36) 2.82 (1.97 to 4.02) 1.67 (1.45 to 1.93) 3.90 (3.45 to 4.40) 
All mutually adjusted for age, calendar period, IMD and Area of England. IMD = Index of Multiple Deprivation.
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increase in opioid poisonings over a similar 
time period. One potential explanation may 
be the increasing opioid prescribing rates in 
the UK. Among >18-year-olds prescriptions 
for weak opioids nearly doubled from 2005–
2012,33 while prescriptions of strong opioids 
increased four- to sixfold from 2000–2012.33,34 
GPs face a number of challenges around 
opioid prescribing including evidence of 
limited long-term benefits for chronic pain,35,36 
alongside often having ethical concerns about 
withholding analgesia.37 Such consultations 
are frequently set in the context of patients 
fearful of an impact on pain management, 
their quality of life or possible dependence. 
However, there is evidence that reducing 
access to lethal means, including medication, 
reduces suicides.2
Limiting prescribing is not the only possible 
approach to reducing poisonings. Educating 
physicians and potentially the public is key, 
with physician education in suicide prevention 
having been shown to reduce suicide rates.2 
There is also evidence that legislation and 
regulations, such as that introduced in the UK 
in 1998 to limit paracetamol pack sizes sold 
over-the-counter, reduces poisoning deaths.1
The finding of a three- to fourfold increase 
in antidepressant poisonings from 1998–
2014 continues the temporal trend among 
12–18 year-olds shown by Hawton et al, 
who demonstrated a more than doubling 
in antidepressant poisonings from 1996–
2000.9 US data showed a near doubling of 
antidepressant poisonings in 13–19-year-
olds between 2004 and 2012.24 Increases 
in antidepressant poisonings may again 
reflect increased UK prescribing. There was 
a 28% increase in antidepressant prescribing 
among 6–18-year-olds from 2003–2013 in 
Wales,38 and a doubling of antidepressant 
prescriptions among >14-year-olds in the 
UK from 1995–2011.39 However, this should 
be considered in light of the fact that higher 
antidepressant prescription rates are actually 
associated with decreasing suicide rates 
through their benefits in treating depression 
itself.2 
In the UK, paracetamol poisonings 
increased during the 1990s but reduced 
around 1998–1999,9,17 most likely due to 
legislation restricting the pack size of 
paracetamol. There is some evidence of 
further increases in the early 2000s.9,13 The 
current study suggests continued increases 
in paracetamol poisoning since then. US 
data, in contrast, shows static paracetamol 
poisoning levels among 13–19-year-olds 
between 2004 and 2013.24
The threefold increase in aspirin/NSAID 
poisonings demonstrated updates earlier UK 
evidence of a more than halving in NSAID 
poisonings among 12–18-year-olds between 
1978–1990 and 1991–2003 and static rates in 
<15-year-olds from 1990–2000.9
The overall increase in poisonings involving 
alcohol is similar to previous findings from 
UK primary care data that reported a 20% 
increase in alcohol poisonings among 
10–17-year-olds between 1992 and 2012.40 
The greater increase among females 
compared to males and the reduction in 
10–15-year-old male alcohol poisonings 
reflect national trends in underage binge 
drinking that have increased from 1995–2011 
among girls but fallen slightly among boys.41
The findings of a social gradient in 
poisonings among young people reflect 
similar findings of 1.5 to threefold increased 
risk in the most compared to least deprived 
groups shown across a variety of countries and 
settings.10,40,42–45 To the authors’ knowledge, 
this social gradient has not previously 
been quantified for individual substances. 
This gradient may reflect differences 
in psychological distress, psychosocial 
stressors, and support46 as well as varied 
social, economic, and physical environments 
across the different socioeconomic groups.47
Implications for research and practice 
Future research to examine poisoning 
incidence in conjunction with individual 
prescription data would be useful to describe 
the source of poisonings substances used by 
young people. 
Alongside physician education, these 
findings primarily suggest volumes of 
medication prescribed to young people 
should be limited. This is especially relevant 
for those with a history of self-harm, where 
similar precautions should be taken when 
prescribing for family members. This 
is important when prescribing for both 
psychiatric and non-psychiatric conditions, 
especially analgesics. Though the largest 
increases in poisonings were seen for 
opioids, adding to the increasing volume of 
recent evidence suggesting the need to curb 
opioid prescribing, this should be seen in 
the context of the most common poisoning 
substances being OTC analgesics. It is 
important for GPs, as well as hospital-based 
clinicians assessing young people after an 
episode of self-harm, to raise awareness 
of the types of substances young people 
use to self-harm with the families of those 
at risk. In particular, that these commonly 
include OTC medications that may be easily 
accessible within households or which young 
people may buy themselves. This is also a 
key message for community pharmacists, 
when selling over-the-counter analgesia to 
young people. 
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